| 注册
首页|期刊导航|军事医学|失血性休克后线粒体损伤及治疗研究进展

失血性休克后线粒体损伤及治疗研究进展

李俊英 刘磊

军事医学2025,Vol.49Issue(11):864-869,6.
军事医学2025,Vol.49Issue(11):864-869,6.DOI:10.7644/j.issn.1674-9960.2025.11.009

失血性休克后线粒体损伤及治疗研究进展

Research advances in mitochondrial injury and treatment following hemorrhagic shock

李俊英 1刘磊2

作者信息

  • 1. 武汉科技大学医学部医学院,武汉 430065
  • 2. 武汉科技大学医学部医学院,武汉 430065||中部战区总医院输血医学科,武汉 430070
  • 折叠

摘要

Abstract

Hemorrhagic shock(HS)is a state of acute circulatory failure caused by massive hemorrhage that results in a sharp decrease in effective circulating blood volume and tissue hypoperfusion.HS easily triggers a series of complex pathophysiological changes,among which mitochondrial dysfunction is regarded as a key link.Mitochondria are the center of cellular energy production,which are involved in the regulation of apoptosis,oxidative stress response and immune regulation.With in-depth studies on the pathophysiological mechanism of HS,the role of mitochondria in HS has received more attention,but the mechanism of action remains elusive.This article reviews the pathophysiological characteristics,molecular regulatory mechanisms and research progress related to therapeutic drugs for mitochondrial injury after HS in order to contribute to subsequent research in this area.

关键词

失血性休克/线粒体损伤/氧化应激/沉默信息调节因子1/线粒体保护剂

Key words

hemorrhagic shock/mitochondrial injury/oxidative stress/silent information regulation 1/mitochondrial protectants

分类

医药卫生

引用本文复制引用

李俊英,刘磊..失血性休克后线粒体损伤及治疗研究进展[J].军事医学,2025,49(11):864-869,6.

基金项目

湖北省医学青年拔尖人才项目[鄂卫通(2023)65号] (2023)

军事医学

1674-9960

访问量0
|
下载量0
段落导航相关论文